Vontobel Holding’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Vontobel Holding’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$475K	Buy	+3,000	New	+$406K	﹤0.01%	1067
2026 Q1	–	Sell	-3,000	Closed	-$366K	–	1524
2025 Q4	$366K	Buy	+3,000	New	+$344K	﹤0.01%	1101

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Vontobel Holding's XBI Position: Q2 2026 in Review

Vontobel Holding reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 39% in Q2 2026, selling an estimated $388K and leaving 4,471 shares worth $708K. The position accounts for ﹤0.01% of the portfolio, ranked #935.

Vontobel Holding first reported a position in XBI in Q4 2020 and has held it in 21 quarters since. The position peaked at $3.61M in Q1 2023. 934 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Vontobel Holding held 4,471 shares of State Street SPDR S&P Biotech ETF worth $708K as of Q2 2026.
Vontobel Holding sold 2,867 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $388K.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of Vontobel Holding's portfolio in Q2 2026, its #935 holding.
Vontobel Holding first reported a position in State Street SPDR S&P Biotech ETF in Q4 2020 and has held it in 21 quarters since.
Vontobel Holding's State Street SPDR S&P Biotech ETF position peaked at $3.61M in Q1 2023.
934 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Vontobel Holding's 13F filing for Q2 2026, filed 3 Aug 2026.